Int. J. Mol. Sci. 2013, 14(3), 4655-4669; doi:10.3390/ijms14034655

Long Non-Coding RNA in Cancer

email and †,* email
Department of Molecular Genetics, Institute of Pathology, University of Ljubljana, SI-1000 Ljubljana, Slovenia These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 1 November 2012; in revised form: 3 January 2013 / Accepted: 31 January 2013 / Published: 26 February 2013
(This article belongs to the Special Issue Regulation by non-coding RNAs)
PDF Full-text Download PDF Full-Text [250 KB, uploaded 26 February 2013 13:31 CET]
Abstract: Long non-coding RNAs (lncRNAs) are pervasively transcribed in the genome and are emerging as new players in tumorigenesis due to their various functions in transcriptional, posttranscriptional and epigenetic mechanisms of gene regulation. LncRNAs are deregulated in a number of cancers, demonstrating both oncogenic and tumor suppressive roles, thus suggesting their aberrant expression may be a substantial contributor in cancer development. In this review, we will summarize their emerging role in human cancer and discuss their perspectives in diagnostics as potential biomarkers.
Keywords: long non-coding RNA; cancer; oncogenic lncRNA; tumor suppressor lncRNA

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Hauptman, N.; Glavač, D. Long Non-Coding RNA in Cancer. Int. J. Mol. Sci. 2013, 14, 4655-4669.

AMA Style

Hauptman N, Glavač D. Long Non-Coding RNA in Cancer. International Journal of Molecular Sciences. 2013; 14(3):4655-4669.

Chicago/Turabian Style

Hauptman, Nina; Glavač, Damjan. 2013. "Long Non-Coding RNA in Cancer." Int. J. Mol. Sci. 14, no. 3: 4655-4669.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert